Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | APEX nuclease (multifunctional DNA repair enzyme) 1 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | DNA repair protein RAD52 | 0.0359 | 0.8472 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0231 | 0.5273 | 0.6807 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0023 | 0.0076 | 0.5 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0023 | 0.0076 | 0.5 |
Brugia malayi | hypothetical protein | 0.003 | 0.0269 | 0.0349 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0023 | 0.0076 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0269 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0048 | 0.0705 | 0.0633 |
Schistosoma mansoni | tar DNA-binding protein | 0.0123 | 0.2574 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0151 | 0.3287 | 0.4263 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0048 | 0.0705 | 0.0633 |
Loa Loa (eye worm) | RNA binding protein | 0.0123 | 0.2574 | 0.3271 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0103 | 0.2092 | 0.2713 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.0434 | 0.0361 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0269 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0434 | 0.0426 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0269 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0123 | 0.2574 | 0.3271 |
Brugia malayi | RNA binding protein | 0.0123 | 0.2574 | 0.3338 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0151 | 0.3287 | 0.4205 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0705 | 0.2516 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0705 | 0.2516 |
Schistosoma mansoni | tar DNA-binding protein | 0.0123 | 0.2574 | 1 |
Onchocerca volvulus | 0.0328 | 0.7711 | 0.5 | |
Brugia malayi | Latrophilin receptor protein 2 | 0.0048 | 0.0705 | 0.0914 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0705 | 0.2516 |
Schistosoma mansoni | tar DNA-binding protein | 0.0123 | 0.2574 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0123 | 0.2574 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0023 | 0.0076 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.0434 | 0.1434 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0434 | 0.0426 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0434 | 0.0426 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.0434 | 0.1434 |
Brugia malayi | hypothetical protein | 0.0328 | 0.7711 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0269 | 0.0253 |
Entamoeba histolytica | DNA repair and recombination protein RAD52, putative | 0.0359 | 0.8472 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0123 | 0.2574 | 0.3338 |
Loa Loa (eye worm) | hypothetical protein | 0.0151 | 0.3287 | 0.4205 |
Loa Loa (eye worm) | hypothetical protein | 0.0103 | 0.2092 | 0.264 |
Brugia malayi | MH2 domain containing protein | 0.0231 | 0.5273 | 0.6838 |
Schistosoma mansoni | tar DNA-binding protein | 0.0123 | 0.2574 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0123 | 0.2574 | 0.3271 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0269 | 1 |
Brugia malayi | TAR-binding protein | 0.0123 | 0.2574 | 0.3338 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0048 | 0.0705 | 0.0823 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0269 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0123 | 0.2574 | 0.2516 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0434 | 0.0426 |
Echinococcus multilocularis | high affinity cAMP specific 3',5' cyclic | 0.042 | 1 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0048 | 0.0705 | 0.0914 |
Brugia malayi | hypothetical protein | 0.0037 | 0.0434 | 0.0563 |
Echinococcus multilocularis | GPCR, family 2 | 0.0048 | 0.0705 | 0.0633 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0269 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0123 | 0.2574 | 0.2516 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0048 | 0.0705 | 0.0633 |
Entamoeba histolytica | Rad52/22 family double-strand break repair protein, putative | 0.0102 | 0.206 | 0.2362 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.0269 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.0269 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.0434 | 0.0361 |
Entamoeba histolytica | hypothetical protein | 0.0102 | 0.206 | 0.2362 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0231 | 0.5273 | 0.6807 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0705 | 0.0823 |
Echinococcus granulosus | GPCR family 2 | 0.0048 | 0.0705 | 0.0633 |
Loa Loa (eye worm) | hypothetical protein | 0.0328 | 0.7711 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0151 | 0.3287 | 0.4263 |
Schistosoma mansoni | hypothetical protein | 0.0103 | 0.2092 | 0.8071 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0023 | 0.0076 | 0.5 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0048 | 0.0705 | 0.0633 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0023 | 0.0076 | 0.0099 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0705 | 0.2516 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0023 | 0.0076 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.7519 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 32.6427 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 36.6257 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.